These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4898952)

  • 21. [Problems in combined radio-cytostatic therapy. 7. Syncarcinolytic studies using 5-fluorouracil, natulan and proresid in Crocker sarcoma 180 of mice].
    Ringleb D; Krieg R; Sauer D
    Strahlentherapie; 1969 Oct; 138(4):423-8. PubMed ID: 5352491
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic effects of podophyllin derivatives on malignant neoplasms].
    Diefenthaeler E; Herter NT
    Hospital (Rio J); 1968 Jan; 73(1):183-95. PubMed ID: 5308491
    [No Abstract]   [Full Text] [Related]  

  • 23. [Proresid in surgical treatment of maxillofacial neoplasms].
    Owiński T; Flieger S
    Czas Stomatol; 1969; 22(5):473-7. PubMed ID: 5256117
    [No Abstract]   [Full Text] [Related]  

  • 24. [Apropos of a case of carcinoma of the ovary].
    Clerc JP
    Gynaecologia; 1968; 165(2):77-8. PubMed ID: 5703823
    [No Abstract]   [Full Text] [Related]  

  • 25. [Remission in severe chronic myeloid leukemia after cytostatic treatment].
    Bross W; Olejak B; Bross T
    Wiad Lek; 1966 Sep; 19(18):1453-6. PubMed ID: 5231825
    [No Abstract]   [Full Text] [Related]  

  • 26. [The association of podophyllum derivatives and cyclophosphamide in the palliative therapy of female pelvic neoplasms].
    Varianti G
    Cancro; 1965; 18(6):526-41. PubMed ID: 4162232
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the problem of the conservative treatment of gastric ulcer collosum].
    Norski T; Slończewski B; Bem Z
    Pol Tyg Lek; 1969 Jun; 24(23):891-3. PubMed ID: 5805042
    [No Abstract]   [Full Text] [Related]  

  • 28. [Contribution to cytostatic therapy in abdominal neoplasms].
    De Paolis S
    Cancro; 1964; 17(6):509-19. PubMed ID: 5835882
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunosuppressive agents in multiple sclerosis. Preliminary trials with Proresid].
    Danielczyk W
    Wien Med Wochenschr; 1968 Nov; 118(44):934-7. PubMed ID: 5710171
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental bases and clinical aspects of the use of 2 antimitotic derivatives of podophyllum].
    Fanchamps A
    J Med (Oporto); 1965 Nov; 58(191):673-92. PubMed ID: 5215285
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experiences with SP-I].
    Furue H; Koizumi H; Nishi I; Hattori T; Yokoyama T
    Gan No Rinsho; 1967 Sep; 13(9):658-62. PubMed ID: 5627165
    [No Abstract]   [Full Text] [Related]  

  • 32. [Favourable response of advanced ovarian cancer to treatment with a podophyllin derivative (SP-I and SP-G)].
    Tomin R
    Srp Arh Celok Lek; 1965 Oct; 93(10):973-9. PubMed ID: 5872509
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical findings in podophyllotoxin derivatives (SP-I-SP-G) in malignant tumors].
    Ohara H; Noto J; Kihara A; Noguchi H; Ishii Y
    Gan No Rinsho; 1968 Feb; 14(2):96-100. PubMed ID: 5244790
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical use of podophyllinic acid ethylhydrazide (SP-I) and podophyllotoxin-beta-o-benzyliden-glucoside (SP-G) in malignant urologic tumors].
    Aso Y; Hoshi Y; Okada K; Koiso K; Murahashi I
    Gan No Rinsho; 1969 May; 15(5):453-7. PubMed ID: 5387577
    [No Abstract]   [Full Text] [Related]  

  • 35. [Action mechanism of cytostatic podophyllum derivates].
    Pohl J; Paeschke KD
    Krebsforsch Krebsbekampf; 1967; 6():130-3. PubMed ID: 6027109
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of SPI, SPG and combination of radiotherapy in the management of certain tumors].
    Uzel R; Adali I; Civelekoğlu E
    Turk Tip Cemiy Mecm; 1967 Feb; 33(2):106-16. PubMed ID: 6040938
    [No Abstract]   [Full Text] [Related]  

  • 37. [The treatment of primary chronic polyarthritis with immunosuppressive cytostatic podophyllin derivatives].
    Gömör B; Szántó L; Görgényi F; Benczur M; Ligetiné Reviczky A; Bányai B; Lörincz G
    Orv Hetil; 1969 Jan; 110(4):181-6. PubMed ID: 5779082
    [No Abstract]   [Full Text] [Related]  

  • 38. Podophyllin-salicylic acid solution in treatment of basal cell carcinomas.
    Nelson LM
    Arch Dermatol; 1966 Apr; 93(4):457-9. PubMed ID: 5862640
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiences with therapy of papillomatosis in children].
    von Riccabona A
    Arch Ohren Nasen Kehlkopfheilkd; 1965; 185(2):697-9. PubMed ID: 5882416
    [No Abstract]   [Full Text] [Related]  

  • 40. [Resistance formation in the cytostatic treatment of carcinomas].
    Heckmann U; Tranckjer AS; Harms J
    Zentralbl Gynakol; 1969 Sep; 91(37):1204-10. PubMed ID: 5368211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.